feed,title,long_url,short_url
Yahoo,Liminal BioSciences Announces Resubmission of Biologics License Application to U.S. Food and Drug Administration for RyplazimÂ® (plasminogen) for Treatment of Congenital Plasminogen Deficiency,https://finance.yahoo.com/news/early-warning-news-release-medalist-165300781.html,https://j.mp/3jUNU8L
